Stonebridge Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.86M Buy
36,455
+7,160
+24% +$2.13M 0.69% 51
2025
Q4
$9.67M Sell
29,295
-595
-2% -$202K 0.67% 48
2025
Q3
$10.3M Sell
29,890
-58
-0.2% -$17.5K 0.74% 46
2025
Q2
$9.34M Sell
29,948
-3,504
-10% -$1.34M 0.71% 48
2025
Q1
$17.5M Buy
33,452
+818
+3% +$418K 1.43% 22
2024
Q4
$16.5M Buy
32,634
+1,369
+4% +$778K 1.33% 23
2024
Q3
$18.3M Sell
31,265
-365
-1% -$206K 1.49% 20
2024
Q2
$16.1M Buy
31,630
+5,571
+21% +$2.73M 1.42% 23
2024
Q1
$12.9M Buy
26,059
+2,112
+9% +$1.07M 1.16% 28
2023
Q4
$12.6M Buy
23,947
+187
+0.8% +$99.7K 1.27% 24
2023
Q3
$12M Buy
23,760
+1,055
+5% +$519K 1.32% 24
2023
Q2
$10.9M Buy
22,705
+759
+3% +$371K 1.16% 28
2023
Q1
$10.4M Buy
21,946
+159
+0.7% +$76.7K 1.18% 30
2022
Q4
$11.6M Buy
21,787
+365
+2% +$193K 1.37% 22
2022
Q3
$10.8M Buy
21,422
+104
+0.5% +$54.7K 1.39% 23
2022
Q2
$10.9M Buy
21,318
+283
+1% +$142K 1.33% 22
2022
Q1
$10.7M Buy
21,035
+571
+3% +$275K 1.16% 30
2021
Q4
$10.3M Buy
20,464
+492
+2% +$223K 1.13% 33
2021
Q3
$7.8M Sell
19,972
-17,530
-47% -$7.26M 0.95% 40
2021
Q2
$14.5M Buy
37,502
+18,915
+102% +$7.54M 0.92% 43
2021
Q1
$6.92M Buy
18,587
+395
+2% +$137K 0.92% 43
2020
Q4
$6.38M Buy
18,192
+215
+1% +$72.1K 0.97% 40
2020
Q3
$5.61M Sell
17,977
-291
-2% -$89.4K 1.01% 41
2020
Q2
$5.39M Sell
18,268
-904
-5% -$259K 1% 37
2020
Q1
$4.78M Sell
19,172
-355
-2% -$97.7K 1.01% 37
2019
Q4
$5.74M Buy
19,527
+74
+0.4% +$19.4K 0.94% 44
2019
Q3
$4.23M Buy
19,453
+14,703
+310% +$3.55M 0.73% 52
2019
Q2
$1.16M Sell
4,750
-2,447
-34% -$589K 0.21% 99
2019
Q1
$1.78M Sell
7,197
-142
-2% -$36.2K 0.33% 83
2018
Q4
$1.83M Sell
7,339
-14
-0.2% -$3.7K 0.43% 69
2018
Q3
$1.96M Sell
7,353
-1,472
-17% -$383K 0.39% 76
2018
Q2
$2.17M Sell
8,825
-740
-8% -$178K 0.47% 66
2018
Q1
$2.05M Buy
9,565
+1,051
+12% +$240K 0.47% 67
2017
Q4
$1.88M Buy
8,514
+2,805
+49% +$594K 0.43% 71
2017
Q3
$1.12M Sell
5,709
-81
-1% -$15.6K 0.27% 89
2017
Q2
$1.07M Sell
5,790
-50
-0.9% -$8.77K 0.28% 89
2017
Q1
$958K Buy
5,840
+3,430
+142% +$562K 0.26% 95
2016
Q4
$386K Sell
2,410
-196
-8% -$29.3K 0.11% 116
2016
Q3
$365K Sell
2,606
-781
-23% -$109K 0.11% 120
2016
Q2
$478K Buy
3,387
+756
+29% +$101K 0.16% 110
2016
Q1
$339K Buy
2,631
+806
+44% +$95.3K 0.12% 117
2015
Q4
$215K Buy
1,825
+50
+3% +$5.84K 0.08% 136
2015
Q3
$206K Buy
+1,775
New +$212K 0.08% 135

Other funds holding UNH

Stonebridge Capital Advisors's UNH Position: Q1 2026 in Review

Stonebridge Capital Advisors increased its UnitedHealth (UNH) stake by 24% in Q1 2026, buying an estimated $2.13M and bringing the position to 36,455 shares worth $9.86M. The position accounts for 0.69% of the portfolio, ranked #51.

Stonebridge Capital Advisors first reported a position in UNH in Q3 2015 and has held it in 43 quarters since. The position peaked at $18.3M in Q3 2024. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Stonebridge Capital Advisors held 36,455 shares of UnitedHealth worth $9.86M as of Q1 2026.
  • Stonebridge Capital Advisors bought 7,160 UnitedHealth shares in Q1 2026, an estimated $2.13M.
  • UnitedHealth made up 0.69% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #51 holding.
  • Stonebridge Capital Advisors first reported a position in UnitedHealth in Q3 2015 and has held it in 43 quarters since.
  • Stonebridge Capital Advisors's UnitedHealth position peaked at $18.3M in Q3 2024.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.